Abstract

This review highlights the diagnostic methods used, the control strategies adopted, and the global epidemiological status of canine cyclic thrombocytopenia and granulocytic anaplasmosis at the animal–human interface. Canine anaplasmosis is an important worldwide disease, mainly caused by Anaplasma platys and A. phagocytophilum with zoonotic implications. A. platys chiefly infects platelets in canids, while A. phagocytophilum is the most common zoonotic pathogen infecting neutrophils of various vertebrate hosts. Diagnosis is based on the identification of clinical signs, the recognition of intracellular inclusions observed by microscopic observation of stained blood smear, and/or methods detecting antibodies or nucleic acids, although DNA sequencing is usually required to confirm the pathogenic strain. Serological cross-reactivity is the main problem in serodiagnosis. Prevalence varies from area to area depending on tick exposure. Tetracyclines are significant drugs for human and animal anaplasmosis. No universal vaccine is yet available that protects against diverse geographic strains. The control of canine anaplasmosis therefore relies on the detection of vectors/reservoirs, control of tick vectors, and prevention of iatrogenic/mechanical transmission. The control strategies for human anaplasmosis include reducing high-risk tick contact activities (such as gardening and hiking), careful blood transfusion, by passing immunosuppression, recognizing, and control of reservoirs/vectors.

Highlights

  • Anaplasmosis is a vector-borne disease that affects animals and humans worldwide [1].It is a virulent non-contagious disease caused by strictly intracellular Gram-negative bacteria

  • Sufficient scientific data are available for A. phagocytophilum, while less epidemiological and risk factor information is available for A. platys

  • Camels infected with A. platys generally remain asymptomatic, with some evidence of anorexia, dullness, progressive loss of physical condition, and stamina, as well as neutrophilia and eosinophilia [22]

Read more

Summary

Introduction

Anaplasmosis is a vector-borne disease that affects animals and humans worldwide [1]. It is a virulent non-contagious disease caused by strictly intracellular Gram-negative bacteria. These pathogens parasitize circulating blood cells (erythrocytes, monocytes, granulocytes, and platelets) [2]. Infectious canine cyclic thrombocytopenia and granulocytic anaplasmosis are two zoonotic diseases caused by A. platys and A. phagocytophilum, respectively, mainly affecting dogs and wild canids [1,2]. Anaplasma platys was first detected in a dog from Florida and frequently infects platelets. A. phagocytophilum primarily infects canine granulocytes (especially neutrophils) of a wide range of domestic and wild vertebrate hosts, as well as humans [6]. Infection with A. phagocytophilum in dogs is known as canine granulocytic anaplasmosis. It is imperative to mention the updated global epidemiological status, diagnosis, and control of canine anaplasmosis at the animal–human interface

History
Etiology
Evolution of Taxonomy
Current Classification
Epidemiology
Anaplasma platys
Anaplasma phagocytophilum
Transmission
Life Cycle
Clinical Findings
Direct Detection
Blue–purple inclusionsofofAnaplasma
Serology
Molecular Detection
Isolation and In Vitro Cultivation
10. Control
10.1. Vector Control
10.3. Chemotherapeutic Use
11. Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.